Cargando…

Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma

Malignant glioma is the most common brain cancer with dismal outcomes. Individual variation of the patients’ survival times is remarkable. Here, we investigated the transcriptome and promoter methylation differences between patients of malignant glioma with short (less than one year) and the patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Huimin, Wang, Zheng, Li, Mingyang, Zeng, Fan, Wang, Kuanyu, Huang, Ruoyu, Wang, Haoyuan, Yang, Fan, Liang, Tingyu, Huang, Hua, Jiang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599690/ https://www.ncbi.nlm.nih.gov/pubmed/28912488 http://dx.doi.org/10.1038/s41598-017-11962-y

Ejemplares similares

CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma
por: Wang, Kuanyu, et al.
Publicado: (2018)

RGS16 promotes glioma progression and serves as a prognostic factor
por: Huang, Ruoyu, et al.
Publicado: (2020)

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma
por: Huang, Lijie, et al.
Publicado: (2020)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas
por: Huang, Ruoyu, et al.
Publicado: (2022)

ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R)
por: Zhang, Ying, et al.
Publicado: (2018)

RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis
por: Zeng, Fan, et al.
Publicado: (2019)

DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines
por: Zhao, Ya-Hui, et al.
Publicado: (2022)

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

Transition of Dephospho-DctD to the Transcriptionally Active State via Interaction with Dephospho-IIA(Glc)
por: Kang, Sebin, et al.
Publicado: (2022)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
por: Tao, Rui, et al.
Publicado: (2023)

Molecular Characterization of AEBP1 at Transcriptional Level in Glioma
por: Wang, Kuanyu, et al.
Publicado: (2021)

Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
por: Wu, Chao, et al.
Publicado: (2019)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma
por: Zeng, Fan, et al.
Publicado: (2020)

Classifying lower grade glioma cases according to whole genome gene expression
por: Chen, Baoshi, et al.
Publicado: (2016)

HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation
por: Cheng, Wen, et al.
Publicado: (2015)

Molecular and clinical characterization of PTRF in glioma via 1,022 samples
por: Sun, Si, et al.
Publicado: (2023)

m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
por: Chai, Rui-Chao, et al.
Publicado: (2019)

Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
por: Wu, Fan, et al.
Publicado: (2017)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
por: Cheng, Wen, et al.
Publicado: (2015)

High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation
por: Huang, Ruoyu, et al.
Publicado: (2021)

A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
por: Wang, Wen, et al.
Publicado: (2016)

Gene expression and DNA methylation analyses suggest that two immune related genes are prognostic factors of colorectal cancer
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Fusion Genes Altered in Adult Malignant Gliomas
por: You, Gan, et al.
Publicado: (2021)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

DDOST Correlated with Malignancies and Immune Microenvironment in Gliomas
por: Chang, Xiaojing, et al.
Publicado: (2022)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma
por: Chen, Fan, et al.
Publicado: (2022)

Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas
por: Liu, Yanwei, et al.
Publicado: (2015)

Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020)

Rab27a Was Identified as a Prognostic Biomaker by mRNA Profiling, Correlated with Malignant Progression and Subtype Preference in Gliomas
por: Wang, Hongjun, et al.
Publicado: (2014)

A potentially effective drug for patients with recurrent glioma: sermorelin
por: Chang, Yuanhao, et al.
Publicado: (2021)

Prognostic significance of ARL9 and its methylation in low-grade glioma
por: Tan, Yutang, et al.
Publicado: (2020)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

A PTEN-COL17A1 fusion gene and its novel regulatory role in Collagen XVII expression and GBM malignance
por: Yan, Xiaoyan, et al.
Publicado: (2017)

Differential and Prognostic Significance of HOXB7 in Gliomas
por: Zhou, Xingang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_406uo6vb9g42oui7glosg7vs8n